Statistical Copolymers for pH-Responsive Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current polymer therapeutics for drug and DNA delivery face challenges in achieving site-specific and controlled gene expression due to limitations in stimuli responsiveness and biocompatibility, particularly in micellar drug delivery systems and polyplexes.
Innovation Solution
The development of statistical copolymers through cationic ring-opening polymerization of 2-oxazoline and 2-oxazine monomers, allowing for the creation of random and gradient copolymers with adjustable monomeric compositions, which can form micellar drug delivery systems and polyplexes with enhanced biocompatibility and responsiveness to environmental stimuli.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional polymer therapeutics are used for drug and DNA delivery, then delivery systems can be formed, but site-specific and controlled gene expression is limited due to insufficient stimuli responsiveness and biocompatibility
Solution Approach 1:
The patent applies parameter changes by incorporating ionizable comonomers with pKa values between 5-8 that respond to pH changes, enabling the polymer to transition between charged and uncharged states. This allows the delivery system to respond to physiological pH gradients, achieving site-specific release and controlled gene expression while improving biocompatibility through pH-triggered conformational changes
Solution Approach 2:
The patent creates composite materials by synthesizing copolymers that combine hydrophobic monomers with ionizable comonomers having specific pKa ranges. This composite structure integrates both drug delivery capabilities and stimuli-responsive behavior, enabling the system to achieve reliable controlled gene expression while adapting to physiological environments through pH-responsive conformational changes
2Adaptability or versatility
If copolymers of MMA with MAc or DMAEMA are used to achieve pH responsiveness, then phase change can be obtained, but the copolymers precipitate at slightly alkaline conditions reducing biocompatibility
Solution Approach 1:
The patent modifies the pKa parameter of the ionizable comonomer to fall within the physiological range of 5-8, which prevents precipitation at alkaline pH while maintaining pH responsiveness. This parameter optimization allows the copolymer to remain soluble and biocompatible across physiological pH conditions while still exhibiting phase change behavior for controlled release
Solution Approach 2:
The patent applies local quality by incorporating ionizable groups with specific pKa characteristics at strategic positions in the polymer chain. This localized functionalization enables pH-responsive behavior in specific regions while maintaining overall biocompatibility and preventing precipitation in alkaline environments through controlled charge distribution
3Adaptability or versatility
If statistical copolymers with ionizable comonomers are synthesized, then stimuli responsiveness is improved, but precise control of monomer composition and sequence distribution becomes more difficult
Solution Approach 1:
The patent applies dynamics by utilizing the inherent statistical nature of copolymerization to create composition gradients along the polymer chain. Rather than attempting to achieve uniform random distribution, the method embraces the dynamic composition variations that naturally occur during polymerization, which actually enhance stimuli responsiveness while simplifying manufacturing control
Solution Approach 2:
The patent controls the manufacturing process by adjusting parameters such as monomer feed ratios, initiator concentration, and reaction temperature to achieve the desired pKa range (5-8) for the ionizable comonomer. These parameter optimizations ensure consistent pH-responsive behavior while accommodating the statistical nature of copolymer composition distribution
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These copolymers exhibit improved biocompatibility and responsiveness, enabling efficient and controlled drug and DNA delivery with reduced interchain repulsion and varied local environments, potentially surpassing the efficiency of traditional delivery methods.
Implementation Method 1
Polymer micelles consisting of amphiphilic block copolymers form a hydrophobic core, in which lipophilic drugs can be physically incorporated. Hydrophilic blocks or segments generate water-friendly corona and encapsulate the hydrophobic core.
Implementation Method 2
Change in pH and therefore in the net charge causes the phase change depending on hydrophobic and hydrophilic balance of the copolymer. MAc is hydrophilic at high pH when COOH groups are deprotonated, but becomes more hydrophobic when—COOH groups are protonated.
Implementation Method 3
Stimuli responsive polymers have sharp and reversible responses to small changes in environmental conditions such as temperature, pH, light, ionic strength, electric and magnetic fields
Data Source
AI summary
The invention relates to invention relates to a statistical copolymer represented by the following formula (I): Ini-[Ox]m-[Oz]n-Nuc (I) wherein: Ini represents a residue of an initiator of cationic polymerization, Nuc represents a residue of a nucleophilic agent, Ox represents N(R1)CHRaCHRa; each R1 independently represents H or C(O)R11; and R11 independently represents optionally substituted C1-12 alkyl, optionally substituted cycloalkyl, optionally substituted aralkyl or optionally substituted aryl; Oz represents N(R2)CHRaCHRaCHRa; each R2 independently represents C(O)R21 or H; and R21 independently represents optionally substituted C1-12 alkyl, optionally substituted cycloalkyl, optionally substituted aralkyl or optionally substituted aryl; each Ra independently represents H, linear or branched C1-3 alkyl; m≥5; n≥5; m+n≥20; 3:97≤m:n≤97:3. The statistical copolymers of the present invention exhibit useful properties that can be exploited in the medical field, especially in polymer micelles for drug delivery and polyplexes for DNA delivery.